Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 4/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18309315 | 0.83 | FOS (0.38) | MAPTKDM4EALDH1A1 | |
| SCHEMBL20328545 | 0.78 | AXL (0.43) | MAPTKMT2AGAAKDM4EALDH1A1 | |
| SCHEMBL17596193 | 0.76 | KDM4E (0.48) | MAPTL3MBTL1KMT2AHTTKDM4E | |
| SCHEMBL31082862 | 0.71 | KDM4E (0.40) | ATMMAPTL3MBTL1KMT2ATSHR | |
| SCHEMBL18299199 | 0.70 | MAPT (0.39) | ATMMAPTL3MBTL1KMT2AOPRK1 | |
| SCHEMBL8590367 | 0.70 | RAB9A (0.47) | ATMMAPTL3MBTL1KMT2ATSHR | |
| SCHEMBL18309296 | 0.69 | CSNK2A1 (0.44) | MAPTL3MBTL1ABL1KDM4EALDH1A1 | |
| SCHEMBL30016982 | 0.69 | KDM4E (0.50) | ATMKDM4EALDH1A1HPGD | |
| SCHEMBL15472009 | 0.69 | ALDH1A1 (0.39) | ATMMAPTKMT2ATSHRGAA | |
| SCHEMBL22120120 | 0.68 | ATM (0.41) | ATMKMT2ATSHRGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180177190-A1 | HERBICIDAL COMPOUNDS | SYNGENTA PARTICIPATIONS AG (CH) | 2018-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180177190-A1 | HERBICIDAL COMPOUNDS | DDT, CYP1B1, ATP1B1 | ATM 4400/4885MAPT 3494/4885L3MBTL1 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.